Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of single-dose FazaClo ODT 12.5 mg in healthy male volunteers
2008-006738-85Phase 4Completed
- Sponsor
- Azur Pharma, Ltd.
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clozapine in schizophrenia (2 arms), sponsored by Azur Pharma, Ltd. Primary endpoint: Effect of food on FazaClo ODT bioavailability and pharmacokinetics. Started Nov 2008; status: completed.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2008-006738-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006738-85.